PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

University of Cincinnati leads first trial on steroid and CNI withdrawal post-transplant

2012-11-28
(Press-News.org) CINCINNATI—The University of Cincinnati will lead a $5.2 million national trial studying removal of both corticosteroids and common immunosuppression treatments from the post-transplant drug regimen for kidney transplant patients.

The Belatacept Early Steroid withdrawal Trial (BEST) seeks to determine if a belatacept-based regimen for post-transplant patients can prevent organ rejection without the harmful side effects posed by corticosteroids and calcineurin inhibitor (CNI) immunosuppressants. Belatacept is a modified version of the drug abatacept, which is used to treat rheumatoid arthritis.

Led by principal investigator and director of UC's division of transplantation E. Steve Woodle, MD, the $5.2 million trial will be carried out at four other transplant centers across the country: University of Wisconsin, University of Minnesota, California Pacific Medical Center and the Christ Hospital in Cincinnati.

The BEST study is the first large, multicenter trial to remove both corticosteroids and CNIs from a patient's drug regimen after kidney transplantation. Both drugs place patients at an increased risk of cardiovascular disease, high blood pressure, high cholesterol and diabetes. Additionally, CNIs have shown toxicity to transplanted kidneys.

"Cardiovascular events like stroke and heart attacks are the top cause of death for both the general population and transplant patients," says Woodle, who also serves as William A. Altemeier Chair in the UC Department of Surgery. "We've previously demonstrated that early steroid withdrawal results in reduced rates of rejection and increased graft survival in transplant patients."

Rita Alloway, PharmD, research professor of medicine and director of transplant clinical research within the UC Department of Internal Medicine, will direct the coordinating center for the trial. She says belatacept was approved by the Food and Drug Administration in 2011 for prevention of rejection in kidney transplant patients—the first FDA-approved drug to replace CNIs like tacrolimus and cyclosporine.

"This trial is a major step forward in immunosuppression because it provides a means to avoid many of the toxicities of the CNI drugs, particularly kidney toxicity, high blood pressure, and hyperlipidemia," says Alloway.

Adele Shields, PhD, associate research professor of surgery with clinical practice at the Christ Hospital, has specialized in quantitating the impact of long-term immunosuppression on cardiac risk factors and cardiac events.

"An important feature of the belatacept-based treatment regimen is that it provides an opportunity to greatly minimize cardiovascular risk in the long term," she says. "By avoiding both CNIs and corticosteroids, this trial provides an opportunity to substantially impact long-term patient survival following kidney transplantation."

### The trial seeks to enroll 315 new kidney transplant patients across all centers. Enrollment will begin December 2012.


ELSE PRESS RELEASES FROM THIS DATE:

NIST releases annual report on federal technology transfer

NIST releases annual report on federal technology transfer
2012-11-28
With new treatments for disease, test suites that safeguard computers, and even expertise to rescue miners trapped thousands of feet underground, federal laboratories have a wealth of technologies and know-how that can give U.S. companies a competitive edge and improve quality of life. These science and technology resources were developed in response to national challenges, but they also can be valuable assets for private industry and academia as well as other government agencies. Each year—as required by federal regulation—the National Institute of Standards and Technology ...

Babies born to mothers from the Philippines significantly smaller than those of Canadian-born women

2012-11-28
TORONTO, Nov. 28, 2012—Babies born in Ontario to mothers from the Philippines have significantly lower birth weights than those whose mothers were born in Canada or elsewhere in East Asia and are twice as likely to be classified as small for their gestational age, a new study has found. The classification is often incorrect, researchers say, because the babies are being compared to those of other ethnic backgrounds. When compared to other Filipino babies, they are well within appropriate heights and weights. The lead author of the study, published online in the Journal ...

New study shows how climate change could affect entire forest ecosystems

New study shows how climate change could affect entire forest ecosystems
2012-11-28
(Santa Barbara, Calif.) –– The fog comes in, and a drop of water forms on a pine needle, rolls down the needle, and falls to the forest floor. The process is repeated over and over, on each pine needle of every tree in a forest of Bishop pines on Santa Cruz Island, off the coast of Santa Barbara. That fog drip helps the entire forest ecosystem stay alive. Thousands of years ago, in cooler and wetter times, Bishop pine trees are thought to have proliferated along the West Coast of the U.S. and Mexico. Now, stratus clouds –– the low-altitude clouds known locally as "June ...

Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread

Scripps Florida scientists uncover a novel cooperative effort to stop cancer spread
2012-11-28
JUPITER, FL, November 28, 2012 – Scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a group of what have been considered relatively minor regulators in the body that band together to suppress the spread of cancer from its primary site. The discovery offers a fresh batch of possible therapeutic targets as well as new diagnostic tools with the potential to predict and inhibit the spread of cancer (metastasis) in patients suffering from the disease. The research, published recently in The Journal of Biological Chemistry, was conducted ...

Fracking in Michigan: U-M researchers study potential impact on health, environment, economy

2012-11-28
ANN ARBOR—University of Michigan researchers are conducting a detailed study of the potential environmental and societal effects of hydraulic fracturing, the controversial natural gas drilling process known as fracking. In hydraulic fracturing, large amounts of water, sand and chemicals are injected deep underground to break apart rock and free trapped natural gas. Though the process has been used for decades, recent technical advances have helped unlock vast stores of previously inaccessible natural gas, resulting in a fracking boom. Now U-M researchers are working ...

Cell phone addiction similar to compulsive buying and credit card misuse, according to Baylor study

2012-11-28
WACO, Texas (Nov. 28, 2012) - Cell phone and instant messaging addictions are driven by materialism and impulsiveness and can be compared to consumption pathologies like compulsive buying and credit card misuse, according to a Baylor University study in the Journal of Behavioral Addictions. A video of Dr. Roberts is available at http://www.baylor.edu/mediacommunications/news.php?action=story&story=125458 "Cell phones are a part of our consumer culture," said study author James Roberts, Ph.D., professor of marketing and the Ben H. Williams Professor of Marketing at Baylor's ...

College students more eager for marriage than their parents

2012-11-28
Reaching adulthood certainly takes longer than it did a generation ago, but new research shows one way that parents are contributing to the delay. A national study found that college students think 25 years old is the "right age" to get married, while a majority of parents feel 25 is still a little too soon. So it's no coincidence that when Justin Bieber said he'd like to wed by 25, Oprah Winfrey urged him to wait longer. "The assumption has been that the younger generation wants to delay marriage and parents are hassling them about when they would get married," said ...

Studies from 2012 Quality Care Symposium highlight findings in improving quality of cancer care

2012-11-28
ALEXANDRIA, Va. – Five additional studies to be presented at the 2012 Quality Care Symposium provide insight on how oncology practices can improve the quality of care they provide. The Symposium will take place November 30 – December 1, at the Manchester Grand Hyatt in San Diego. Note to Media: Statements from ASCO Communications Committee Member, Jyoti Patel, MD, can be cited throughout can be used in part or in their entirety. Abstract #69 Rates of diagnostic imaging in long-term survivors of young adult malignancies Corinne Daly, BSc, MSc Institute of Medical ...

Researchers report first success of targeted therapy in most common non-small cell lung cancer

Researchers report first success of targeted therapy in most common non-small cell lung cancer
2012-11-28
BOSTON - A new study by an international team of investigators led by Dana-Farber Cancer Institute scientists is the first to demonstrate that chemotherapy and a new, targeted therapy work better in combination than chemotherapy alone in treating patients with the most common genetic subtype of lung cancer. Published online today in The Lancet Oncology, the combination of chemotherapy and the targeted drug selumetinib was more effective than chemotherapy alone in a clinical trial involving patients with a form of non-small cell lung cancer (NSCLC) that carries a mutation ...

Joslin researchers increase understanding of genetic risk factor for type 1 diabetes

Joslin researchers increase understanding of genetic risk factor for type 1 diabetes
2012-11-28
BOSTON – November 28, 2012 – As part of their ongoing research on the role of genes in the development of type 1 diabetes, Joslin Diabetes Center scientists, in collaboration with scientists at the University of Würzburg, have demonstrated how a genetic variant associated with type 1 diabetes and other autoimmune diseases influences susceptibility to autoimmunity. The findings appear in the upcoming issue of Diabetes. Recent studies of the human genome have identified genetic regions associated with autoimmune diseases such as type 1 diabetes. Joslin scientists in the ...

LAST 30 PRESS RELEASES:

Thirty years of research shows increased resistance in fungi

Junk food ‘avoids advertising regulation’ with top level UK sports sponsorship

Banking on AI while committed to net zero is ‘magical thinking’, claims report on energy costs of big tech

Ancient river systems reveal Mars was wetter than we thought

Online toolkit to help parents of autistic children improve dental health

The psychological and neurological parallels between sports fandom and religious devotion

Agricultural liming in the US is a large CO2 sink, say researchers

Seaside more likely to make us nostalgic than green places, study finds

Psilocybin delays aging, extends lifespan, Emory study suggests

Buck Institute awarded DARPA contract to pioneer next-gen AI modeling platform

Orange is the new aphrodisiac—for guppies

Murals boost Cincinnati’s vitality, community development

Ad blockers may be showing users more problematic ads, NYU Tandon study finds

Verbal response time reveals hidden sleepiness in older adults

University of Maryland School of Medicine launches groundbreaking study on THC/CBD therapy for dementia-related agitation at end of life

Targeting stem-property and vasculogenic mimicry for sensitizing paclitaxel therapy of triple-negative breast cancer by biomimetic codelivery

SRSF7 promotes pulmonary fibrosis through regulating PKM alternative splicing in lung fibroblasts

Psychological stress-activated NR3C1/NUPR1 axis promotes ovarian tumor metastasis

An anti-complement homogeneous polysaccharide from Houttuynia cordata ameliorates acute pneumonia with H1N1 and MRSA coinfection through rectifying Treg/Th17 imbalance in the gut–lung axis and NLRP3 i

ALKBH3-regulated m1A of ALDOA potentiates glycolysis and doxorubicin resistance of triple negative breast cancer cells

A photodynamic nanohybrid system reverses hypoxia and augment anti-primary and metastatic tumor efficacy of immunotherapy

Acta Pharmaceutica Sinica B Volume 15, Issue 6 Publishes

From injury to agony: Scientists discover brain pathway that turns pain into suffering

Molecular simulations show graphite ‘hijacks’ diamond formation through unexpected crystallization pathways

Scientific breakthrough uses cold atoms to unlock cosmic mysteries 

First-of-its-kind journal facilitates rapid publication of AI research

AI tool helps improve detection of cardiac amyloidosis

Loneliness predicts poor mental and physical health outcomes

Keeping the photon in the dark

FDA-approved drugs could make nano-medicine safer, study finds

[Press-News.org] University of Cincinnati leads first trial on steroid and CNI withdrawal post-transplant